A risk vs benefit calculation does not support giving COVID-19 vaccines, which use novel technologies and are still in Phase 3 trials, to healthy children. Any rollout should not start until trials are complete and all findings are published and peer-reviewed on long-term safety data.
Special to WorldTribune, May 26, 2021 Commentary by R. Clinton Ohlers In a recent Zoom call, Dr. Pierre Kory of the Front Line COVID-19 Critical Care Alliance outlined numerous details showing the …
India’s decision to adopt ivermectin, including as a prophylaxis in some states, is already a potential game-changer...
To earn tokens and access the decentralized web, select an option below
(It's easier than you think)
No thanks, I'll do it later